Proof-of-Concept Screening Studies

In partnership with Immunaccel, our platform is used to provide a “quick” screen and preliminary dataset using  HLA-matched CTL and Tumor lines and Keytruda Resistant TIL and Tumor.

Custom 3D Platform Build

Using patient derived cell lines and cells we tailor modules that capture disease environments to study drug mechanism of actions and functions. We welcome collaborations with companies to leverage our intellectual property, know-how and cell lines in building novel IMMUNE 3D® platforms.

Target Discovery Partnerships

Our platform has extensive data to support IO drug discovery efforts. We are seeking partnerships with like-minded companies where our scientific know-how, capabilities and data can be expanded upon to deliver innovative targets.